These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987 [TBL] [Abstract][Full Text] [Related]
28. Rapid phenotyping of knockout mice to identify genetic determinants of bone strength. Freudenthal B; Logan J; ; Croucher PI; Williams GR; Bassett JH J Endocrinol; 2016 Oct; 231(1):R31-46. PubMed ID: 27535945 [TBL] [Abstract][Full Text] [Related]
29. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Koay MA; Brown MA Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771 [TBL] [Abstract][Full Text] [Related]
31. The cellular basis of metabolic bone disease. Rasmussen H; Bordier P N Engl J Med; 1973 Jul; 289(1):25-32. PubMed ID: 4575395 [No Abstract] [Full Text] [Related]
32. LRP receptor family member associated bone disease. Lara-Castillo N; Johnson ML Rev Endocr Metab Disord; 2015 Jun; 16(2):141-8. PubMed ID: 26048454 [TBL] [Abstract][Full Text] [Related]
33. LRP4 in neuromuscular junction and bone development and diseases. Shen C; Xiong WC; Mei L Bone; 2015 Nov; 80():101-108. PubMed ID: 26071838 [TBL] [Abstract][Full Text] [Related]
34. Integration of endocytosis and signal transduction by lipoprotein receptors. May P; Bock HH; Herz J Sci STKE; 2003 Apr; 2003(176):PE12. PubMed ID: 12671190 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of bone repair and regeneration. Deschaseaux F; Sensébé L; Heymann D Trends Mol Med; 2009 Sep; 15(9):417-29. PubMed ID: 19740701 [TBL] [Abstract][Full Text] [Related]
36. Gender specific LRP5 influences on trabecular bone structure and strength. Dubrow SA; Hruby PM; Akhter MP J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087 [TBL] [Abstract][Full Text] [Related]
37. Endocytic receptor-mediated control of morphogen signaling. Willnow TE; Christ A; Hammes A Development; 2012 Dec; 139(23):4311-9. PubMed ID: 23132241 [TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
39. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. Linton MF; Hasty AH; Babaev VR; Fazio S J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504 [TBL] [Abstract][Full Text] [Related]